SEC Form 4 · accession 0000899243-18-016986
EyePoint, Inc. · EYPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dario A. Paggiarino
Officer — Chief Medical Officer
Period of report
Jun 14, 2018
Accepted (ET)
Jun 18, 2018 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001314102
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jun 14, 2018 | A | 42,600 | A | — | — | Common Stock | 42,600 | 42,600 | D |
| Stock Option (right to buy)F3 | $2.04 | Jun 14, 2018 | A | 170,500 | A | — | Jun 14, 2028 | Common Stock | 170,500 | 170,500 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- F2The restricted stock units will vest in three equal annual installments beginning June 14, 2019. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
- F3The option to purchase will vest and become exercisable in three equal annual installments beginning June 14, 2019.